TechnoPhage, SA - From science to innovative biopharmaceuticals
Collaborative manuscripts between TechnoPhage and the Faculty of Pharmacy of the University of Lisbon on the characterization of lysins against Methicillin-Resistant Staphylococcus aures (MRSA) accepted for publication
Collaborative manuscripts between TechnoPhage and the Faculty of Pharmacy of the University of Lisbon on the characterization of lysins against Enterococcus faecalis accepted for publication
TechnoPhage and SIMM signed a collaboration agreement, announced at AICEP Portugal Global, involving a collaboration in both pre-clinical and future clinical studies of TA101 for the treatment of Rheumatoid Arthritis to market TA101 in the People's Republic of China.